IRadimed (Germany) Price Prediction
| 46K Stock | EUR 86.50 2.50 2.98% |
Momentum 66
Buy Stretched
Oversold | Overbought |
Using IRadimed hype-based prediction, you can estimate the value of IRadimed from the perspective of IRadimed response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in IRadimed to buy its stock at a price that has no basis in reality. In that case, they are not buying IRadimed because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
IRadimed after-hype prediction price | EUR 86.5 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
IRadimed |
IRadimed After-Hype Price Prediction Density Analysis
As far as predicting the price of IRadimed at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in IRadimed or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of IRadimed, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
IRadimed Estimiated After-Hype Price Volatility
In the context of predicting IRadimed's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on IRadimed's historical news coverage. IRadimed's after-hype downside and upside margins for the prediction period are 84.67 and 88.33, respectively. We have considered IRadimed's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
IRadimed is very steady at this time. Analysis and calculation of next after-hype price of IRadimed is based on 3 months time horizon.
IRadimed Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as IRadimed is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading IRadimed backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with IRadimed, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.59 | 1.83 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
86.50 | 86.50 | 0.00 |
|
IRadimed Hype Timeline
IRadimed is presently traded for 86.50on Frankfurt Exchange of Germany. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. IRadimed is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is estimated to be very small, whereas the daily expected return is presently at 0.59%. %. The volatility of related hype on IRadimed is about 0.0%, with the expected price after the next announcement by competition of 86.50. About 44.0% of the company shares are owned by insiders or employees . The company has Price/Earnings (P/E) ratio of 452.94. IRadimed last dividend was issued on the 10th of February 2023. Assuming the 90 days horizon the next estimated press release will be in 5 to 10 days. Check out IRadimed Basic Forecasting Models to cross-verify your projections.IRadimed Related Hype Analysis
Having access to credible news sources related to IRadimed's direct competition is more important than ever and may enhance your ability to predict IRadimed's future price movements. Getting to know how IRadimed's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how IRadimed may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ABL | Abbott Laboratories | 0.00 | 0 per month | 0.00 | (0.13) | 2.51 | (1.70) | 6.12 | |
| AFW | Align Technology | 0.00 | 0 per month | 1.39 | 0.15 | 4.55 | (2.33) | 9.40 | |
| 94P | AUREA SA INH | 0.00 | 0 per month | 2.55 | 0.03 | 4.65 | (3.93) | 14.39 | |
| 8SP | Superior Plus Corp | 0.00 | 0 per month | 0.00 | (0.07) | 1.91 | (1.84) | 22.41 | |
| DVDG | Franklin Global Quality | 0.00 | 0 per month | 2.53 | 0 | 0.96 | (0.65) | 30.48 | |
| IUI1 | INTUITIVE SURGICAL | 0.00 | 0 per month | 1.00 | 0.12 | 3.40 | (2.56) | 19.61 | |
| INL | Intel | 0.00 | 0 per month | 3.03 | 0.1 | 7.68 | (5.40) | 16.35 | |
| VOW | Volkswagen AG | 0.00 | 0 per month | 0.99 | 0.07 | 2.12 | (1.53) | 6.95 | |
| RS6 | Reliance Steel Aluminum | 0.00 | 0 per month | 1.28 | 0.04 | 2.72 | (2.41) | 6.14 | |
| RRU | Rolls Royce Holdings plc | 0.00 | 0 per month | 2.07 | 0.03 | 3.53 | (3.36) | 8.23 |
IRadimed Additional Predictive Modules
Most predictive techniques to examine IRadimed price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for IRadimed using various technical indicators. When you analyze IRadimed charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About IRadimed Predictive Indicators
The successful prediction of IRadimed stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as IRadimed, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of IRadimed based on analysis of IRadimed hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to IRadimed's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to IRadimed's related companies.
Story Coverage note for IRadimed
The number of cover stories for IRadimed depends on current market conditions and IRadimed's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that IRadimed is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about IRadimed's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Complementary Tools for IRadimed Stock analysis
When running IRadimed's price analysis, check to measure IRadimed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IRadimed is operating at the current time. Most of IRadimed's value examination focuses on studying past and present price action to predict the probability of IRadimed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IRadimed's price. Additionally, you may evaluate how the addition of IRadimed to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |